Diagnostic Ability of Dynamic Contrast-Enhanced Magnetic Resonance Imaging for Prostate Cancer and Clinically Significant Prostate Cancer in Equivocal Lesions: A Systematic Review and Meta-Analysis

Diagnostic Ability of Dynamic Contrast-Enhanced Magnetic Resonance Imaging for Prostate Cancer and Clinically Significant Prostate Cancer in Equivocal Lesions: A Systematic Review and Meta-Analysis

BackgroundDynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) now has been used to diagnose prostate cancer (PCa). Equivocal lesions are defined as PIRADS category 3 or a Likert scale of 1 to 5 category 3 lesions. Currently, there are no clear recommendations for the management of these l...

Full description

Bibliographic Details
Main Authors: Jing Zeng, Qingqing Cheng, Dong Zhang, Meng Fan, Changzheng Shi, Liangping Luo
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-02-01
Series:Frontiers in Oncology
Subjects:
DCE-MRI
dynamic contrast-enhanced magnetic resonance imaging
prostate cancer
clinically significant prostate cancer
equivocal lesions
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2021.620628/full

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2021.620628/full

Similar Items